Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    16533249 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Reveal® XT Performance Trial (XPECT)
Conditions: Atrial Fibrillation;   Risk of Cardiac Arrhythmias
Intervention: Other: 46 hrs Holter ECG recording
2 Completed
Has Results
Tailored Treatment of Permanent Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: Medtronic Cardiac Ablation System;   Drug: Class I or III Antiarrhythmic Medications

Study has passed its completion date and status has not been verified in more than two years.